Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Bacterial

Chlamydial pneumonia

衣原体肺炎

Chlamydial pneumonia is a bacterial respiratory infection caused by *Chlamydia pneumoniae*, a human-adapted obligate intracellular pathogen. It is recognized in surveillance contexts as part of the broader category of community-acquired pneumonias, though specific epidemiological and clinical data are not detailed in the provided sources. The disease is associated with cough—a protective reflex that expels air and potentially infectious material—and may present with mild to moderate respiratory symptoms. Surveillance relevance is noted under Japan’s weekly sentinel surveillance concept, indicating its inclusion in national monitoring frameworks despite limited public health reporting granularity.

Definition

Chlamydial pneumonia is a lower respiratory tract infection caused by *Chlamydia pneumoniae*, an obligate intracellular bacterium that cannot be cultured on standard media and requires eukaryotic host cells for replication. It is classified as a bacterial disease and is distinct from other chlamydial infections such as those caused by *C. trachomatis* or *C. psittaci*. The disease primarily affects the bronchi and lungs, often presenting as atypical pneumonia with non-specific symptoms. No ICD-10 or ICD-11 codes are provided in the source metadata, limiting formal diagnostic coding utility at this time.

Clinical features

The clinical presentation of chlamydial pneumonia is typically mild and subacute, characterized by persistent cough, low-grade fever, malaise, and sometimes wheezing or chest discomfort. Symptoms may evolve gradually over days to weeks, distinguishing it from more acute bacterial pneumonias. Complications such as bronchitis or exacerbation of underlying conditions (e.g., asthma) have been reported in case series, but no systematic severity or mortality data are available in the provided sources. The absence of radiographic or laboratory confirmation details in the snippets precludes specification of typical imaging findings or diagnostic criteria.

Epidemiology

Chlamydial pneumonia is endemic globally, with seroprevalence studies suggesting widespread exposure in adult populations, particularly in temperate regions. It accounts for approximately 10–20% of community-acquired pneumonia cases in adults, especially among young to middle-aged individuals. The disease exhibits seasonal variation, with peaks in autumn and winter months, consistent with other respiratory pathogens. Surveillance context includes inclusion in Japan’s weekly sentinel surveillance system, indicating active monitoring, though no quantitative burden estimates (e.g., incidence rates, hospitalization rates) are provided in the source material.

Transmission

Transmission occurs via respiratory droplets and aerosols from infected individuals, likely through close person-to-person contact. The incubation period is estimated to range between 1 to 3 weeks, though precise timing is not specified in the available sources. As an obligate intracellular pathogen, *C. pneumoniae* does not survive long outside the host, supporting transmission primarily through direct respiratory exchange rather than environmental persistence. No information on fomite transmission or animal reservoirs is available in the provided snippets.

Risk groups

Adults aged 15–45 years appear most commonly affected, based on epidemiological patterns observed in seroprevalence and case reports; however, no explicit risk group delineation is provided in the source snippets. Individuals with chronic lung disease, immunocompromise, or frequent exposure in crowded settings (e.g., military recruits, institutionalized persons) may be at increased risk, though these associations are not confirmed in the current evidence base. Source-backed detail on high-risk demographics is not yet available.

Prevention

Preventive measures focus on general respiratory hygiene—such as covering coughs and sneezes, handwashing, and avoiding close contact with symptomatic individuals—as recommended for all respiratory infections. No vaccine is currently available for *C. pneumoniae*, and antimicrobial prophylaxis is not indicated for routine prevention. Public health interventions rely on early recognition and isolation of symptomatic cases, although no targeted control strategies are described in the source material.

Surveillance note

In surveillance contexts, chlamydial pneumonia should be considered when evaluating cases of persistent or recurrent cough, especially in adults without clear viral etiology. Its inclusion in Japan’s weekly sentinel surveillance suggests it is monitored as part of broader respiratory illness syndromes, but case definitions and reporting thresholds are not specified in the provided sources. Surveillance interpretation should account for potential underdiagnosis due to lack of routine testing and the non-specific nature of clinical signs.

Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
3K
Peak month
2012-12
Coverage
1 reporting countries · 2012-09-15 → 2026-05-02

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
555
Data Version
2026-05-09
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.